Drugmaker Ariad Pharmaceuticals has subleased 160,000 square feet at its new build-to-suit site at 75/125 Binney St. in Cambridge’s Kendall Square to IBM.

Alexandria Real Estate Equities is developing the 386,000-square-foot office and lab building for Ariad, which leased the entire building in 2013. Since then, Ariad has suffered financial setbacks following the removal of its Iclusig blood cancer drug from the U.S. market.

The 10-year sublease takes effect Aug. 20 and totals $114.5 million, according to a regulatory filing by Ariad.

Ariad Subleases 160,000 Square Feet To IBM In Kendall Square

by Banker & Tradesman time to read: <1 min
0